Active Ingredient: DALBAVANCIN HYDROCHLORIDE
Proprietary Name: DALVANCE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: EQ 500MG BASE/VIAL
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N021883
Product Number: 001
Approval Date: May 23, 2014
Applicant Holder Full Name: ABBVIE INC
Marketing Status:
Prescription
Patent and Exclusivity Information
